CDSCO Panel Gives Conditional nod to Azelnidipine and Olmesartan FDC MD Bureau18 Jan 2021 1:21 PM GMTNew Delhi: Following the submission of bioequivalence (BE) study report by Akum Drugs, the Central Drug Standard Control...
Effective BP control: High dose ARB monotherapy or combination therapy of ARB and CCB for hypertension? Dr. Prem Aggarwal10 Oct 2020 5:00 AM GMTHypertension (HTN) is a global health hazard and a leading cause of mortality and morbidity. It is ranked third as a cause for disability-adjusted...
Impact of Combination Therapy on Arterial Stiffness and Cardiac Function in hypertensive patients: Lessons from AORTA II Trial Dr. Prem Aggarwal28 July 2020 7:00 AM GMTManagement of Blood pressure (BP) in patients is a highly individualized affair. When adequate blood pressure control is not be obtained by...
Combination therapy for Hypertension: Olmesartan plus Azelnidipine or Olmesartan plus Amlodipine? Dr. Prem Aggarwal14 July 2020 7:15 AM GMTThe Protocol of Controlling Blood pressure (BP) in Hypertensive Patients is different in different parts of the world. Achieving adequate blood...
Olmesartan-Induced Enteropathy: A Case report Hina Zahid25 May 2020 12:00 PM GMTDr Ana Rita Fernandes Matos at Serviço de Medicina Interna, Hospital de Braga, Braga, Portugal and associates have reported a case of...
